Viewing Study NCT00355095


Ignite Creation Date: 2025-12-24 @ 2:17 PM
Ignite Modification Date: 2026-02-01 @ 9:01 PM
Study NCT ID: NCT00355095
Status: COMPLETED
Last Update Posted: 2012-09-13
First Post: 2006-07-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis
Sponsor: Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Optic Neuritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None multiple sclerosis View
None add-on Therapy View
None erythropoietin View
None methylprednisolone View
None autoimmune optic neuritis View